These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 17383101

  • 21. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS, Tsujimoto N, Qu Q, Lei H, Li E, Chen T, Blaustein CS.
    Neuroreport; 2008 Mar 05; 19(4):393-8. PubMed ID: 18287934
    [Abstract] [Full Text] [Related]

  • 22. Rett syndrome: from the gene to the disease.
    Matijevic T, Knezevic J, Slavica M, Pavelic J.
    Eur Neurol; 2009 Mar 05; 61(1):3-10. PubMed ID: 18948693
    [Abstract] [Full Text] [Related]

  • 23. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M, Zoghbi HY.
    Neuron; 2007 Nov 08; 56(3):422-37. PubMed ID: 17988628
    [Abstract] [Full Text] [Related]

  • 24. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
    Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM.
    Neurobiol Dis; 2006 Jan 08; 21(1):217-27. PubMed ID: 16087343
    [Abstract] [Full Text] [Related]

  • 25. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.
    Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, Missler M, Zhang W.
    J Neurophysiol; 2008 Jan 08; 99(1):112-21. PubMed ID: 18032561
    [Abstract] [Full Text] [Related]

  • 26. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.
    Belichenko PV, Wright EE, Belichenko NP, Masliah E, Li HH, Mobley WC, Francke U.
    J Comp Neurol; 2009 May 20; 514(3):240-58. PubMed ID: 19296534
    [Abstract] [Full Text] [Related]

  • 27. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P, Zoghbi HY.
    Curr Opin Genet Dev; 2006 Jun 20; 16(3):276-81. PubMed ID: 16647848
    [Abstract] [Full Text] [Related]

  • 28. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE, Johnston MV, Blue ME.
    Brain Dev; 2005 Nov 20; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
    Francke U.
    Nat Clin Pract Neurol; 2006 Apr 20; 2(4):212-21. PubMed ID: 16932552
    [Abstract] [Full Text] [Related]

  • 30. Rett syndrome: of girls and mice--lessons for regression in autism.
    Glaze DG.
    Ment Retard Dev Disabil Res Rev; 2004 Apr 20; 10(2):154-8. PubMed ID: 15362175
    [Abstract] [Full Text] [Related]

  • 31. Breeding and maintenance of an Mecp2-deficient mouse model of Rett syndrome.
    Jugloff DG, Logan R, Eubanks JH.
    J Neurosci Methods; 2006 Jun 30; 154(1-2):89-95. PubMed ID: 16439027
    [Abstract] [Full Text] [Related]

  • 32. Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome.
    Nag N, Berger-Sweeney JE.
    Neurobiol Dis; 2007 May 30; 26(2):473-80. PubMed ID: 17395475
    [Abstract] [Full Text] [Related]

  • 33. Regional MeCP2 expression levels in the female MeCP2-deficient mouse brain correlate with specific behavioral impairments.
    Wither RG, Lang M, Zhang L, Eubanks JH.
    Exp Neurol; 2013 Jan 30; 239():49-59. PubMed ID: 23022455
    [Abstract] [Full Text] [Related]

  • 34. Reduced proportion of Purkinje cells expressing paternally derived mutant Mecp2308 allele in female mouse cerebellum is not due to a skewed primary pattern of X-chromosome inactivation.
    Watson CM, Pelka GJ, Radziewic T, Shahbazian MD, Christodoulou J, Williamson SL, Tam PP.
    Hum Mol Genet; 2005 Jul 01; 14(13):1851-61. PubMed ID: 15888476
    [Abstract] [Full Text] [Related]

  • 35. Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome.
    Buoni S, Zannolli R, Felice CD, Saponari S, Strambi M, Dotti MT, Castrucci E, Corbini L, Orsi A, Hayek J.
    Clin Neurophysiol; 2008 Nov 01; 119(11):2455-8. PubMed ID: 18842453
    [Abstract] [Full Text] [Related]

  • 36. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
    Lang M, Wither RG, Brotchie JM, Wu C, Zhang L, Eubanks JH.
    Hum Mol Genet; 2013 Jan 15; 22(2):358-71. PubMed ID: 23077217
    [Abstract] [Full Text] [Related]

  • 37. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.
    Ricceri L, De Filippis B, Laviola G.
    Behav Pharmacol; 2008 Sep 15; 19(5-6):501-17. PubMed ID: 18690105
    [Abstract] [Full Text] [Related]

  • 38. Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice.
    Kerr B, Alvarez-Saavedra M, Sáez MA, Saona A, Young JI.
    Hum Mol Genet; 2008 Jun 15; 17(12):1707-17. PubMed ID: 18321865
    [Abstract] [Full Text] [Related]

  • 39. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J, Wu H, Sun YE.
    Int Rev Neurobiol; 2009 Jun 15; 89():147-60. PubMed ID: 19900619
    [Abstract] [Full Text] [Related]

  • 40. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations.
    Temudo T, Oliveira P, Santos M, Dias K, Vieira J, Moreira A, Calado E, Carrilho I, Oliveira G, Levy A, Barbot C, Fonseca M, Cabral A, Dias A, Cabral P, Monteiro J, Borges L, Gomes R, Barbosa C, Mira G, Eusébio F, Santos M, Sequeiros J, Maciel P.
    Neurology; 2007 Apr 10; 68(15):1183-7. PubMed ID: 17420401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.